Back
Education Programme
State-of-the-Art: Immunotherapy for ALL Treatment
VIVA-Asia Rare Tumour Board
The Cognitive and Psychological Burden in Young Cancer Patients/Survivors
26th October 2024, Saturday
10:30AM – 1:30PM (GMT+8 SG Time)* | Check your Time Zone
8 Sinaran Dr, #03-01 VIVA-Hub, Novena Specialist Center, Singapore 307470 & Online via Zoom
Join renowned experts in the field of ALL treatment as they share their insights on the role of novel agents in improving outcomes. Led by keynote speakers Dr Kwong Yok Lam, Dr Allen Yeoh, and Dr Federico Lussana, this conference will highlight both regional and global experiences in treating Ph- and Ph+ ALL across adult and pediatric populations. Hosted by VIVA, this event is a vital step forward in the global fight to save more lives.
📆 Date: Saturday, 26th October 2024
⏰ Time: 10:30 AM – 1:30 PM (UTC+8)
Venue: 8 Sinaran Dr, #03-01 VIVA-Hub, Novena Specialist Center, Singapore 307470 & Online via Zoom
If you can’t make it, you can still register to receive a copy of the webinar recording.
Medical professionals in Singapore may eligible for CME/CPE/CNE credits for attending this webinar.
Credits and Certificates of Attendance will only be issued for those who are able to attend the live session and are in adherence with VIVA’s Attendance Policy.
PROGRAMME TIMETABLE
SYPNOSIS
Dr Federico Lussana
- Dr Lussana will share international experience from GIMEMA working group on using novel agents (e.g.,blinatumomab, CART etc) for treatment of Philadelphia-Negative/Positive acute lymphoblastic leukemia, focusing on optimal timing of incorporating novel agent(s), role of minimal residual disease, role of transplant in the era of novel agent(s) etc.
Dr Kwong Yok Lam
- Dr Kwong will share experience from Hong Kong in using novel agent(s) to treat Adult Philadelphia-Negative acute lymphoblastic leukemia (ALL) to improve patient outcome.
Dr Hany Ariffin
- Dr Hany will share experience from Ma-Spore study group in using novel agent(s) to treat Childhood Philadelphia-Positive acute lymphoblastic leukemia (ALL) to improve patient outcome.
Dr Wong Gee Chuan
- Dr Wong will share experience from Singapore General Hospital in using novel agent(s) to treat Adult Philadelphia-Positive acute lymphoblastic leukemia (ALL) to improve patient outcome.
Dr Bunchoo Pongtanakul
- Dr Bunchoo will share experience from ThaiPOG working group in using novel agent(s) to treat Childhood Philadelphia-Negative acute lymphoblastic leukemia (ALL) to improve patient outcome.
WATCH IT AGAIN!
SPEAKERS
Dr Federico Lussana
Assistant Professor of Hematology of the Department of Oncology and Hematology at the University of Milan.
Part of the Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO) working group.
Inspector for Hematopoietic stem cell Transplant Programs on behalf Joint Accreditation Committee ISCT-EBMT (JACIE)
Italy
Dr Bunchoo Pongtanakul
A/Professor, Division of Pediatrics Hematology and Oncology, Medicine Siriraj Hospital, Mahidol University
Member of Thai Paediatric Oncology Group (ThaiPOG)
Thailand
Dr Hany Ariffin
Professor of Paediatrics and Head of the Division of Paediatric Haematology-Oncology and Blood & Marrow Transplantation at the University of Malaya Medical Centre (UMMC)
Malaysia
Dr Wong Gee Chuan
A/Professor, Senior Consultant, Director of Acute Leukemia Service, Department of Haematology, Singapore General Hospital
Member, Acute Leukemia Service Singapore General Hospital & Acute Leukemia Working Group, Singapore
Singapore
CO-CHAIRS
Dr Yok Lam Kwong
Professor, Chief of the Division of Hematology,
Oncology and BMT, Department of Medicine,
Queen Mary Hospital, The University of Hong Kong
Hong Kong
Dr Allen Yeoh
Professor, Department of Paediatrics, Viva-Goh Foundation Professor in Paediatric Oncology, Head & Senior Consultant, Division of Paediatric Haematology and Oncology, Yong Loo Lin School of Medicine, National University of Singapore
$30.00
Materials Includes
- Certificate of Completion
- Lorem Ipsum
- Lorem Ipsum
Requirements
- Access to a computer with an internet connection.
- No programming experience needed
- No paid software required
Tags
Register for the programme
"*" indicates required fields